ProPhase Labs, Inc. (PRPH)
0.13
-0.01
(-7.14%)
USD |
NASDAQ |
Dec 05, 16:00
0.129
0.00 (0.00%)
Pre-Market: 08:34
ProPhase Labs Shareholders Equity (Quarterly): 6.861M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| FONAR Corp. | 174.87M |
| XWELL, Inc. | -6.333M |
| Veracyte, Inc. | 1.258B |
| Insight Molecular Diagnostics, Inc. | -9.196M |
| Exagen, Inc. | 18.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.70M |
| Total Liabilities (Quarterly) | 58.84M |
| Debt to Equity Ratio | 1.12 |
| Current Ratio | 0.1406 |
| Net Debt Paydown Yield | 16.46% |